Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$55,165
+$1,397 QoQ
Shares Held
352
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,423
of 1,603 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$39,240
PutShares
352
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quaker Wealth Management, LLC holds $2,542,311 across 13 Drug Manufacturers - General names. NVS ranks #11 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,097 | $786,545 | |
| 2 | LLY |
ELI LILLY & Co
|
466 | $558,934 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,499 | $321,121 | |
| 4 | ABBV |
AbbVie Inc.
|
969 | $243,839 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,038 | $131,140 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,138 | $123,191 | |
| 7 | PFE |
Pfizer Inc
|
3,608 | $86,880 | |
| 8 | AMGN |
Amgen Inc
|
224 | $81,114 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,165 | 352 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $53,768 | 352 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $52,528 | 381 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $45,140 | 352 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $42,595 | 352 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $39,240 | 352 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||